SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-09-102397
Filing Date
2009-05-07
Accepted
2009-05-07 06:21:49
Documents
4
Period of Report
2009-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14626
2 PRESS RELEASE DATED MAY 7, 2009 dex991.htm EX-99.1 53761
3 GRAPHIC g10198g37i36.jpg GRAPHIC 1335
4 GRAPHIC g10198g61b95.jpg GRAPHIC 2292
  Complete submission text file 0001193125-09-102397.txt   75207
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 09803400
SIC: 2834 Pharmaceutical Preparations